Carly Kenselaar

Stock Analyst at Citigroup

(3.07)

# 1,206

Out of 4,757 analysts

6

Total ratings

80%

Success rate

65.6%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$31 → $35	$18.94	+84.79%	5	Feb 24, 2025

	KRYS Krystal Biotech	Initiates: Buy	$160	$178.93	-10.58%	1	Oct 12, 2023

Travere Therapeutics

Feb 24, 2025

Maintains: Buy

Price Target: $31 → $35

Current: $18.94

Upside: +84.79%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $178.93

Upside: -10.58%